EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Guanidines: Privileged Scaffolds Against Neglected Tropical Diseases: A Review

Luana Ribeiro Dos Anjos iD, Rodrigo Santos Aquino de Araújo iD, Malu Maria Lucas Dos Reis iD, Natalia C S Costa iD, Vitória Gaspar Bernardo, Eduardo Henrique Zampieri iD, Klinger Antonio da Franca Rodrigues iD, Eduardo Maffud Cilli iD, Eduardo René Pérez González iD, Francisco Jaime Bezerra Mendonça-Junior iD

Pharmaceuticals · 17.05.2026 · 19 (5) · 784

DOI: 10.3390/ph19050784 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 17.05.2026. Verfasst von Luana Ribeiro Dos Anjos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fine Organic Chemistry Laboratory School of Sciences and Technology, São Paulo State University (UNESP), Presidente Prudente 19060-080, São Paulo, Br…. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação de Apoio à Pesquisa do Estado da Paraíba.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neglected diseases caused by protozoan parasites remain a major public health burden, particularly in low- and middle-income countries. Among the chemical motifs explored in antiparasitic drug discovery, guanidine-containing compounds have attracted considerable attention due to their strong cationic character, high capacity for hydrogen bonding, and versatility in interacting with biological targets. Methodology: This review summarizes advances reported in the last decade regarding guanidine derivatives with activity against pathogens associated with Chagas disease, human African trypanosomiasis, Leishmaniasis, tuberculosis, toxoplasmosis, dengue and schistosomiasis.

Results

Evidence gathered from synthetic, natural, and drug-repurposing studies indicates that the guanidine, guanidine-containing and guanidine-related compounds contribute to modulating biological activity by changing electrostatic interactions, hydrogen-bonding networks, and physicochemical properties, with enzymes, nucleic acids, and membrane-associated targets essential for parasite survival. Across the analyzed studies, several emerging structure–activity relationship trends were identified, including the contribution of polycationic or dicationic architectures, the influence of halogenated or lipophilic substituents, and the dependence of biological activity on the complete molecular framework, including heterocyclic systems, macrocycles, peptide conjugates, hybrid scaffolds, and repurposed drugs. In addition to direct antiparasitic effects, certain guanidine-containing and guanidine-related compounds demonstrate immunomodulatory or host-protective properties, expanding the therapeutic relevance of this class. Despite promising in vitro results, protonation trapping, efflux pump susceptibility, and pharmacokinetic limitations such as poor oral absorption, high polarity, plasma protein binding and limited membrane permeability remain significant challenges for clinical translation. Nonetheless, the integration of medicinal chemistry, computational modeling, and biological screening continues to accelerate the identification of optimized scaffolds.

Conclusions

Overall, guanidine-based compounds constitute a promising scaffold for the development of new therapeutic strategies targeting neglected parasitic diseases, and further structural optimization may enable the emergence of candidates with improved efficacy, selectivity, and drug-like properties.

Schlagwörter

Stichwörter der Autor:innen

antiparasitic compoundsdrug discoveryguanidine derivativesmedicinal chemistryneglected diseasesstructure–activity relationship

Autor:innen und Institutionen

  • Fine Organic Chemistry Laboratory School of Sciences and Technology, São Paulo State University (UNESP), Presidente Prudente 19060-080, São Paulo, Brazil.
  • Federal Institute of Education, Science, and Technology os Sertão Pernambucano (IFSertãoPE), Campus Santa Maria da Boa Vista, Santa Maria da Boa Vista 56380-000, Pernambuco, Brazil.
  • Laboratory of Synthesis and Drug Delivery, Department of Biological Sciences, State University of Paraíba, João Pessoa 58071-160, Paraíba, Brazil.
  • Department of Biochemistry and Organic Chemistry, Institute of Chemistry, São Paulo State University (UNESP), Araraquara 14800-060, São Paulo, Brazil.
  • Post-Graduate Program in Therapeutic Innovation, Biological Sciences Center, Federal University of Pernambuco, Recife 50670-420, Pernambuco, Brazil.
  • Infectious Disease Laboratory-LADIC, Federal University of Parnaíba Delta-UFDPar, Campus Ministro Reis Velloso, São Benedito, Parnaíba 64202-020, Piauí, Brazil.

ORCID-Profile: Luana Ribeiro Dos Anjos, Rodrigo Santos Aquino de Araújo, Malu Maria Lucas Dos Reis, Natalia C S Costa, Eduardo Henrique Zampieri, Klinger Antonio da Franca Rodrigues, Eduardo Maffud Cilli, Eduardo René Pérez González, Francisco Jaime Bezerra Mendonça-Junior

Förderung

  • National Council for Scientific and Technological Development
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Fundação de Apoio à Pesquisa do Estado da Paraíba
  • São Paulo Research Foundation
  • the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) from Brazil
  • the Coordenaçãoo de Aperfeiçoamento de Pessoal de Nível Superior
  • Paraiba State Research Foundation (FAPESQ-PB) through the PRONEX program
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) through FAPESP APR

Zitieren

APA

Dos Anjos, L. R., de Araújo, R. S. A., Dos Reis, M. M. L., Costa, N. C. S., Bernardo, V. G., Zampieri, E. H., Rodrigues, K. A. D. F., Cilli, E. M., González, E. R. P., & Mendonça-Junior, F. J. B. (2026). Guanidines: Privileged Scaffolds Against Neglected Tropical Diseases: A Review. Pharmaceuticals, 19(5), 784. https://doi.org/10.3390/ph19050784

Vancouver

Dos Anjos LR, de Araújo RSA, Dos Reis MML, Costa NCS, Bernardo VG, Zampieri EH, et al. Guanidines: Privileged Scaffolds Against Neglected Tropical Diseases: A Review. Pharmaceuticals. 2026;19(5):784. doi:10.3390/ph19050784

BibTeX
@article{DosAnjos2026,
  author = {Dos Anjos, Luana Ribeiro and de Araújo, Rodrigo Santos Aquino and Dos Reis, Malu Maria Lucas and Costa, Natalia C S and Bernardo, Vitória Gaspar and Zampieri, Eduardo Henrique and Rodrigues, Klinger Antonio da Franca and Cilli, Eduardo Maffud and González, Eduardo René Pérez and Mendonça-Junior, Francisco Jaime Bezerra},
  title = {Guanidines: Privileged Scaffolds Against Neglected Tropical Diseases: A Review},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {5},
  pages = {784},
  doi = {10.3390/ph19050784}
}
Kostenlos starten →